These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

950 related items for PubMed ID: 31794723

  • 1. First-trimester maternal serum alpha fetoprotein is associated with ischemic placental disease.
    Dinglas C, Afsar N, Cochrane E, Davis J, Kim S, Akerman M, Wells M, Chavez M, Herrera K, Heo H, Vintzileos A.
    Am J Obstet Gynecol; 2020 May; 222(5):499.e1-499.e6. PubMed ID: 31794723
    [Abstract] [Full Text] [Related]

  • 2. Elevated maternal serum alpha-fetoprotein levels and midtrimester placental abnormalities in relation to subsequent adverse pregnancy outcomes.
    Williams MA, Hickok DE, Zingheim RW, Luthy DA, Kimelman J, Nyberg DA, Mahony BS.
    Am J Obstet Gynecol; 1992 Oct; 167(4 Pt 1):1032-7. PubMed ID: 1384333
    [Abstract] [Full Text] [Related]

  • 3. Association between maternal characteristics, abnormal serum aneuploidy analytes, and placental abruption.
    Blumenfeld YJ, Baer RJ, Druzin ML, El-Sayed YY, Lyell DJ, Faucett AM, Shaw GM, Currier RJ, Jelliffe-Pawlowski LL.
    Am J Obstet Gynecol; 2014 Aug; 211(2):144.e1-9. PubMed ID: 24631707
    [Abstract] [Full Text] [Related]

  • 4. Pregnancy outcomes in nulliparous women with positive first-trimester preterm preeclampsia screening test: the Great Obstetrical Syndromes cohort study.
    Boutin A, Guerby P, Gasse C, Tapp S, Bujold E.
    Am J Obstet Gynecol; 2021 Feb; 224(2):204.e1-204.e7. PubMed ID: 32777265
    [Abstract] [Full Text] [Related]

  • 5. The association between maternal serum alpha-fetoprotein and preterm birth, small for gestational age infants, preeclampsia, and placental complications.
    Waller DK, Lustig LS, Cunningham GC, Feuchtbaum LB, Hook EB.
    Obstet Gynecol; 1996 Nov; 88(5):816-22. PubMed ID: 8885920
    [Abstract] [Full Text] [Related]

  • 6. Obstetrical complications associated with abnormal maternal serum markers analytes.
    Gagnon A, Wilson RD, SOCIETY OF OBSTETRICIANS AND GYNAECOLOGISTS OF CANADA GENETICS COMMITTEE.
    J Obstet Gynaecol Can; 2008 Oct; 30(10):918-932. PubMed ID: 19038077
    [Abstract] [Full Text] [Related]

  • 7. Uterine artery Doppler velocimetry in the detection of adverse obstetric outcomes in women with unexplained elevated maternal serum alpha-fetoprotein levels.
    Konchak PS, Bernstein IM, Capeless EL.
    Am J Obstet Gynecol; 1995 Oct; 173(4):1115-9. PubMed ID: 7485303
    [Abstract] [Full Text] [Related]

  • 8. The role of maternal homocysteine concentration in placenta-mediated complications: findings from the Ottawa and Kingston birth cohort.
    Chaudhry SH, Taljaard M, MacFarlane AJ, Gaudet LM, Smith GN, Rodger M, Rennicks White R, Walker MC, Wen SW.
    BMC Pregnancy Childbirth; 2019 Feb 19; 19(1):75. PubMed ID: 30782144
    [Abstract] [Full Text] [Related]

  • 9. Placental protein levels in maternal serum are associated with adverse pregnancy outcomes in nulliparous patients.
    Parry S, Carper BA, Grobman WA, Wapner RJ, Chung JH, Haas DM, Mercer B, Silver RM, Simhan HN, Saade GR, Reddy UM, Parker CB, Nulliparous Pregnancy Outcomes Study: Monitoring Mothers-to-Be Group.
    Am J Obstet Gynecol; 2022 Sep 19; 227(3):497.e1-497.e13. PubMed ID: 35487327
    [Abstract] [Full Text] [Related]

  • 10. First-trimester maternal serum alpha-fetoprotein is not a good predictor for adverse pregnancy outcomes: a retrospective study of 3325 cases.
    Hu J, Zhang J, He G, Zhu S, Tang X, Su J, Li Q, Kong Y, Zhu B.
    BMC Pregnancy Childbirth; 2020 Feb 12; 20(1):104. PubMed ID: 32050927
    [Abstract] [Full Text] [Related]

  • 11. First-trimester screening for early and late preeclampsia using maternal characteristics, biomarkers, and estimated placental volume.
    Sonek J, Krantz D, Carmichael J, Downing C, Jessup K, Haidar Z, Ho S, Hallahan T, Kliman HJ, McKenna D.
    Am J Obstet Gynecol; 2018 Jan 12; 218(1):126.e1-126.e13. PubMed ID: 29097177
    [Abstract] [Full Text] [Related]

  • 12. Association between isolated abnormal levels of maternal serum unconjugated estriol in the second trimester and adverse pregnancy outcomes.
    Settiyanan T, Wanapirak C, Sirichotiyakul S, Tongprasert F, Srisupundit K, Luewan S, Traisrisilp K, Tongsong T.
    J Matern Fetal Neonatal Med; 2016 Jan 12; 29(13):2093-7. PubMed ID: 27480207
    [Abstract] [Full Text] [Related]

  • 13. The comparison of placental abruption coupled with and without preeclampsia and/or intrauterine growth restriction in singleton pregnancies.
    Ni S, Wang X, Cheng X.
    J Matern Fetal Neonatal Med; 2021 May 12; 34(9):1395-1400. PubMed ID: 31248311
    [Abstract] [Full Text] [Related]

  • 14. Maternal First-Trimester Alpha-Fetoprotein and Placenta-Mediated Pregnancy Complications.
    Melamed N, Okun N, Huang T, Mei-Dan E, Aviram A, Allen M, Abdulaziz KE, McDonald SD, Murray-Davis B, Ray JG, Barrett J, Kingdom J, Berger H, for DOH-NET (Diabetes, Obesity and Hypertension in Pregnancy Research Network) and SOON (Southern Ontario Obstetrical Network) Investigators.
    Hypertension; 2023 Nov 12; 80(11):2415-2424. PubMed ID: 37671572
    [Abstract] [Full Text] [Related]

  • 15. Modified multiple marker aneuploidy screening as a primary screening test for preeclampsia.
    Huang T, Bedford HM, Rashid S, Rasasakaram E, Priston M, Mak-Tam E, Gibbons C, Meschino WS, Cuckle H, Mei-Dan E.
    BMC Pregnancy Childbirth; 2022 Mar 08; 22(1):190. PubMed ID: 35260099
    [Abstract] [Full Text] [Related]

  • 16. Associations between adverse perinatal outcome and serially obtained second- and third-trimester maternal serum alpha-fetoprotein measurements.
    Simpson JL, Palomaki GE, Mercer B, Haddow JE, Andersen R, Sibai B, Elias S.
    Am J Obstet Gynecol; 1995 Dec 08; 173(6):1742-8. PubMed ID: 8610755
    [Abstract] [Full Text] [Related]

  • 17. Mid-trimester maternal serum AFP and hCG as markers of preterm and term adverse pregnancy outcomes.
    Tancrède S, Bujold E, Giguère Y, Renald MH, Girouard J, Forest JC.
    J Obstet Gynaecol Can; 2015 Feb 08; 37(2):111-6. PubMed ID: 25767942
    [Abstract] [Full Text] [Related]

  • 18. Second-trimester maternal serum marker screening: maternal serum alpha-fetoprotein, beta-human chorionic gonadotropin, estriol, and their various combinations as predictors of pregnancy outcome.
    Yaron Y, Cherry M, Kramer RL, O'Brien JE, Hallak M, Johnson MP, Evans MI.
    Am J Obstet Gynecol; 1999 Oct 08; 181(4):968-74. PubMed ID: 10521763
    [Abstract] [Full Text] [Related]

  • 19. The association of abnormal alpha-fetoprotein and adverse pregnancy outcome: does increased fetal surveillance affect pregnancy outcome?
    Huerta-Enochian G, Katz V, Erfurth S.
    Am J Obstet Gynecol; 2001 Jun 08; 184(7):1549-53; discussion 1553-5. PubMed ID: 11408879
    [Abstract] [Full Text] [Related]

  • 20. Histopathologic evaluation of dichorionic twin placentas in unassisted and in vitro fertilized pregnancies affected by preeclampsia.
    Manvelyan E, Millington KA, Abittan BS, Blitz MJ, Kwait B, Shan W, Goldman RH.
    J Matern Fetal Neonatal Med; 2022 Dec 08; 35(26):10262-10270. PubMed ID: 36167346
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 48.